Your Friendly Neighborhood Authority Community
OpenEvidence is leveraging a partnership with a top cancer center to bolster its oncology capabilities, adding trusted genomic interpretation expertise to the AI platform already used by millions o | The partnership builds on OpenEvidence’s vision to develop “medical super-intelligence” based on agentic artificial intelligence, or a system of AI agents that can be subspecialists in clinical areas.
Originally Appeared Here
Click here to get the deets! (oh, and did I mention... it's free?)
